Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Nantkwest, Inc.

TRADE

NASDAQ: NKHealthcare / Biotechnology / USA
2.28-0.03-1.30%Vol 228 2131Y Perf -46.82%
Nov 16th, 2018 16:00
BID2.27 ASK2.28
Open2.29 Previous Close2.31
Pre-Market- After-Trading2.28
 - -%  - -%
Target Price
4.00 
Analyst Rating
Moderate Sell 3.67
Potencial %
75.44 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
★+     38.48
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)181 
Earnings Rating
Neutral
Price Range Ratio 52wk %
7.80 
Earnings Date
20th Nov 2018

Today's Price Range

2.152.34

 

52wk Range

2.015.47

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Buy
Performance
1 Month
-20.83%
3 Months
-28.30%
6 Months
-41.84%
1 Year
-46.82%
3 Years
-84.49%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
NK2.28-0.0300-1.30
AAPL193.532.12001.11
GOOG1 061.49-3.2200-0.30
MSFT108.291.01000.94
XOM78.960.77000.98
WFC52.940.12000.23
JNJ145.991.49001.03
FB139.53-4.3200-3.00
GE8.02-0.1500-1.84
JPM109.99-0.0800-0.07
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 2.80
Current Ratio 3.30
Long Term Debt to Total Capital 0.04
Total Debt to Equity 0.05
Interest Coverage -321.70
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-199 227.00
EBITDA Margin-183 194.00
Pre-tax Profit Margin-118 609.00
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.34
PS Ratios 4 188.88
Price to Cash Flow -
Price to Free Cash Flow -2.90
Cash Flow Per Share -0.69
Price to Tangible Book1.35
Book Value per Share2.29
Enterprise Value (in ths.)138 224
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-50.10
ROE last 12 Months -51.71
Return on Assets (5Y Avg) -38.58
ROA last 12 Months -43.13
Return on Capital (5Y Avg) -
ROC last 12 Months -51.24
Return on invested Capital Q -13.38
Return on invested Capital Y-38.22
Assets Turnover0.00
Receivables Turnover0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)52
Revenue per Share 0.00
Revenue Growth 3 Years -40.37
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.37-0.3018.92
Q01 2018-0.34-0.35-2.94
Q04 2017--0.31-
Q02 2017-0.32-0.299.38
Q01 2017-0.39-0.3023.08
Q02 2016-0.35-0.41-17.14
Q01 2016-0.24-0.38-58.33
Q03 2015-0.07-0.55-685.71
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.367.69Positive
12/2018 QR-0.377.50Positive
12/2018 FY-1.472.00Positive
12/2019 FY-1.650.00-
Next Report Date20th Nov 2018
Estimated EPS Next Report-0.37
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume228 213
Shares Outstanding (in ths.)79 230
Trades Count1 032
Dollar Volume437 804
Avg. Volume289 966
Avg. Weekly Volume487 066
Avg. Monthly Volume1 259 232
Avg. Quarterly Volume485 580

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

10%90%

Bearish Bullish

61%39%

Bearish Bullish

72%28%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (66.67 %)
3 (100.00 %)
3 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (33.33 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Sell
3.67
Hold
3.00
Hold
3.00

There are no comments yet.

News

x